Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Core Scientific (CORZ) Accounts Payables: 2021-2024

Historic Accounts Payables for Core Scientific (CORZ) over the last 4 years, with Dec 2024 value amounting to $19.3 million.

  • Core Scientific's Accounts Payables rose 3162.28% to $212.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $212.2 million, marking a year-over-year increase of 3162.28%. This contributed to the annual value of $19.3 million for FY2024, which is 87.55% down from last year.
  • According to the latest figures from FY2024, Core Scientific's Accounts Payables is $19.3 million, which was down 87.55% from $154.8 million recorded in FY2023.
  • Core Scientific's 5-year Accounts Payables high stood at $154.8 million for FY2023, and its period low was $11.6 million during FY2021.
  • Moreover, its 3-year median value for Accounts Payables was $53.6 million (2022), whereas its average is $75.9 million.
  • As far as peak fluctuations go, Core Scientific's Accounts Payables surged by 361.75% in 2022, and later slumped by 87.55% in 2024.
  • Yearly analysis of 4 years shows Core Scientific's Accounts Payables stood at $11.6 million in 2021, then skyrocketed by 361.75% to $53.6 million in 2022, then spiked by 188.49% to $154.8 million in 2023, then tumbled by 87.55% to $19.3 million in 2024.